Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholesterol Supplementation in Smith-Lemli-Opitz Syndrome
NCT00272844Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jan 1998
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cholesterol emulsion in Smith-Lemli-Opitz syndrome (SLOS), sponsored by Boston Children's Hospital. Started Jan 1998; status: completed.
02
Drugs
cholesterol emulsion
03
Conditions
Smith-Lemli-Opitz syndrome (SLOS)
Beyond the preview
Go deeper on NCT00272844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272844.